EDITORIAL

1. ls there a need for universal double reflex testing of HBsAg-positive individuals for hepatitis D infection?

REVIEW

1. Non-alcoholic fatty liver disease and sleep disorders
2. Amebic liver abscess: An update

MINIREVIEWS

1. Advances in discovery of novel investigational agents for functional cure of chronic hepatitis B: A comprehensive review of phases ll and lll therapeutic agents
2. Protein succinylation, hepatic metabolism, and liver diseases
3. Hepatocellular carcinoma immune microenvironment and check point inhibitors-current status

ORIGINAL ARTICLE

1. Associations of PNPLA3 and LEP genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virus
2. Comparison of fungal vs bacterial infections in the medical intensive liver unit: Cause or corollary for high mortality?
3. Lean body mass index is a marker of advanced tumor features in patients with hepatocellular carcinoma
4. Prediction model for hepatitis B e antigen seroconversion in chronic hepatitis B with peginterferon-alfa treated based on a responseguided therapy strategy
5. Retrospective study of the incidence, risk factors, treatment outcomes of bacterial infections at uncommon sites in cirrhotic patients
6. Palliative long-term abdominal drains vs large volume paracenteses for the management of refractory ascites in end-stage liver disease
7. Comprehensive prognostic and immune analysis of sterol Oacyltransferase 1 in patients with hepatocellular carcinoma

SYSTEMATIC REVIEWS

1. Update in lean metabolic dysfunction-associated steatotic liver disease

META-ANALYSIS

1. lnfluence of nonalcoholic fatty liver disease on response to antiviral treatment in patients with chronic hepatitis B: A meta-analysis
2. Prognostic value of neutrophil-to-lymphocyte ratio in end-stage liver disease: A meta-analysis